ZFIN Image: Tonon et al., 2022, Figure 3

Image

Figure Caption

Figure 3 Figure 3. Effects of 5-Aza on miR expression and effects of miR-139-5p on cell viability and migration. (a) Differentially expressed miRs following 6 μM 5-Aza treatments in JHH-6 evaluated by microarray analysis. (b) Viability of JHH-6 treated with both antagomiR-139-5p (100 nM) and 5-Aza. Data, normalized to the average of JHH-6 scr + 5-Aza, are represented as mean ± SEM, n = 3; JHH-6 antagomiR-139-5p vs. JHH-6 scr, ^# p = 0.0123; JHH-6 antagomiR-139-5p + 5-Aza vs. JHH-6 scr + 5-Aza, * p = 0.0001. (c) Viability of HuH-7 treated by both antagomiR-139-5p and 5-Aza. Data, normalized to the average of HuH-7 scr + 5-Aza, are represented as mean ± SEM, n = 3. HuH-7 antagomiR-139-5p vs. HuH-7 scr, ^# p = 0.0065; HuH-7 antagomiR-139-5p + 5-Aza vs. HuH-7 scr + 5-Aza, * p = 0.0001. (d) Migration of JHH-6 treated with both antagomiR-139-5p and 5-Aza. JHH-6 antagomiR-139-5p + 5-Aza vs. JHH-6 miR scr + 5-Aza, * p = 0.002. Data are presented as mean ± SEM, n = 3.

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Cancers